Laboratory Illustrative image Ridgefield, Conn., U.S., and Ingelheim, Germany Zongertinib would be the first orally ...

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

The Lung Cancer Research Foundation (LCRF) is pleased to announce its partnership with Israel Cancer Research Fund (ICRF) on ...

Get Instant Summarized Text (Gist) For stage IA non-small cell lung cancer, lobectomy and segmentectomy are linked to better long-term survival compared to wedge resection. Lobectomy shows ...

In 2025, the American Cancer Society anticipates around 124,730 deaths due to lung cancer. The five-year relative survival rate of small cell lung cancer—the odds that a cancer patient will live ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.

Korea: A recent study published in the Radiology Journal has highlighted the significant role of obesity and skeletal muscle ...

Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...

The results of CheckMate 77T showcase the improved event-free survival for patients with resectable non–small cell lung cancer who receive nivolumab in both the neoadjuvant and adjuvant setting ...